Main text {#Sec1}
=========

Qihong Que. and colleagues \[[@CR1]\] found that liraglutide exhibited anti-inflammatory activity through the activation of the PKA/CREB pathway in an OA rat model. We believe there was a flaw in this research. In their first experiment, the sacrifice time of the 10 rats in the control group has not been stated. And when the rats in the OA-1, OA-5, OA-10, OA-20 and OA-28 groups were sacrificed, they were in different weeks of age. If the rats in the control group were compared to the rats in the OA-1, OA-5, OA-10, OA-20 and OA-28 groups respectively, the results may be biased due to differences in the week age of the rats. We believe that addressing this issue could further increase the value of their study.
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Conclusions {#Sec2}
===========

Qihong Que. and colleagues found that liraglutide exhibited anti-inflammatory activity through the activation of the PKA/CREB pathway in an OA rat model. We believe there was a flaw in this research.

CREB

:   cyclic adenosine monophosphate (cAMP) response element-binding

OA

:   osteoarthritis

PKA

:   protein kinase A

**Publisher's Note**

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Not applicable.

LW was a major contributor in writing the manuscript. All authors read and approved the final manuscript.

No funding was obtained for this study.

Not applicable.

Not applicable.

Not applicable.

The authors declare that they have no competing interests.
